Works matching IS 22873651 AND DT 2024 AND VI 13 AND IP 4

Results: 10
    1
    2

    Safety and immunogenicity of PIKA-adjuvanted recombinant SARS-CoV-2 spike protein subunit vaccine as a booster against SARS-CoV-2: a phase II, open-label, randomized, double-blinded study.

    Published in:
    Clinical & Experimental Vaccine Research, 2024, v. 13, n. 4, p. 329, doi. 10.7774/cevr.2024.13.4.329
    By:
    • Lim, Renan James;
    • Xiangyan Qiu;
    • Alberto, Edison;
    • Rosario Capeding, Maria;
    • Carlos, Josefina;
    • Leong, Robert Neil;
    • Gutierrez, Jose Limuel;
    • Trillana, Maricris;
    • Yuan Liu;
    • Mojares, Zenaida
    Publication type:
    Article
    3
    4
    5
    6
    7

    Anti-severe acute respiratory syndrome coronavirus 2 spike receptor-binding domain antibody levels in patients with systemic lupus erythematosus based on vaccination status and related factors in Indonesia.

    Published in:
    Clinical & Experimental Vaccine Research, 2024, v. 13, n. 4, p. 348, doi. 10.7774/cevr.2024.13.4.348
    By:
    • Hamijoyo, Laniyati;
    • Philo, Patrick;
    • Nathan, Daniel Setiawan;
    • Tiara, Marita Restie;
    • Mardiana, Sofie Razyanti;
    • Susandi, Evan;
    • Ghassani, Nadia Gita;
    • Alisjahbana, Bachti
    Publication type:
    Article
    8
    9

    Safety, tolerability, and immunogenicity of PIKA-adjuvanted recombinant SARS-CoV-2 spike protein subunit vaccine in healthy adults: an open-label randomized phase I clinical trial.

    Published in:
    Clinical & Experimental Vaccine Research, 2024, v. 13, n. 4, p. 315, doi. 10.7774/cevr.2024.13.4.315
    By:
    • Lim, Renan James;
    • Xiangyan Qiu;
    • Leong, Robert Neil;
    • Gutierrez, Jose Limuel;
    • Halima, Ahmad;
    • Mostafa, Mohamed;
    • Ghoneim, Yasser;
    • Abdrabo, Mostafa;
    • Rashad, Moaz;
    • Hannawi, Suad;
    • Yuan Liu;
    • Mojares, Zenaida
    Publication type:
    Article
    10